Skip to main content
Erschienen in: Intensive Care Medicine 6/2019

24.04.2019 | Original

Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study

verfasst von: Jean-Francois Timsit, Carole Schwebel, Lenka Styfalova, Muriel Cornet, Philippe Poirier, Christiane Forrestier, Stéphane Ruckly, Marie-Christine Jacob, Bertrand Souweine

Erschienen in: Intensive Care Medicine | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Respiratory tract Candida spp. colonization is associated with more frequent bacterial ventilator-associated pneumonia (VAP). However, this colonization could be causally related to VAP or simply reflect the immune paralysis associated with multiple organ failure.

Objective

To prospectively evaluate the relationship between Candida spp. colonization and bacterial VAP in mechanically ventilated patients with multiple organ failure.

Inclusion

Patients receiving mechanical ventilation for > 4 days and presenting multiple organ failure were included. Tracheal colonization with Candida spp. was evaluated at inclusion (day 0, D0) and every 4 days until extubation. Quantitative proximal and tracheal cultures were performed at each VAP episode. Monocyte human leukocyte antigen-DR isotype (mHLA-DR) expression and the ratio of polymononuclear leukocytes to lymphocytes were used to evaluate immunoparalysis at D0 and D7. The relationship between fungal colonization and VAP was modelled using cause-specific models for repeated events with adjustment for time-dependent confounders and immune factors.

Results

A total of 213 patients, with a median age of 64, simplified acute physiology score II (SAPS II) score 55 and sequential organ failure assessment (SOFA) score 10, mainly admitted for medical reasons (n = 197, 92%), were enrolled in 2012–2015. The median ICU stay was 24 days and the mortality rate was 32% (69 cases). Median mHLA-DR was 5916 Ab-bound/cell [3863–8934]; median lymphocyte count, 0.9Giga/L [0.6–1.3]; neutrophil-to-lymphocyte ratio, 10.9 [6.5–19.7]. Overall, 146 cases (68.5%) had tracheal colonization with Candida spp. An episode of VAP occurred (either for the first or only time) in 62 (29.1%) cases 5.5 days (median) after D0; a second episode occurred in 12 (5.6%) cases, 15.5 days (median) after D0. After adjustment, bronchial colonization with Candida was not associated with VAP [adjusted cause-specific hazard ratio = 0.98 (0.59–1.65), p = 0.95].

Conclusion

In patients with mechanical ventilation for more than 4 days and multiple organ failure, bronchial colonization with Candida spp. was not associated with VAP, even after adjustment for immune function.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Hamet M, Pavon A, Dalle F, Pechinot A, Prin S, Quenot JP, Charles PE (2012) Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia. Intensive Care Med 38:1272–1279CrossRefPubMed Hamet M, Pavon A, Dalle F, Pechinot A, Prin S, Quenot JP, Charles PE (2012) Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia. Intensive Care Med 38:1272–1279CrossRefPubMed
2.
Zurück zum Zitat Williamson DR, Albert M, Perreault MM, Delisle MS, Muscedere J, Rotstein C, Jiang X, Heyland DK (2011) The relationship between Candida species cultured from the respiratory tract and systemic inflammation in critically ill patients with ventilator-associated pneumonia. Can J Anaesth J Can D’ Anesth 58:275–284CrossRef Williamson DR, Albert M, Perreault MM, Delisle MS, Muscedere J, Rotstein C, Jiang X, Heyland DK (2011) The relationship between Candida species cultured from the respiratory tract and systemic inflammation in critically ill patients with ventilator-associated pneumonia. Can J Anaesth J Can D’ Anesth 58:275–284CrossRef
3.
Zurück zum Zitat Delisle MS, Williamson DR, Perreault MM, Albert M, Jiang X, Heyland DK (2008) The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients. J Crit Care 23:11–17CrossRefPubMed Delisle MS, Williamson DR, Perreault MM, Albert M, Jiang X, Heyland DK (2008) The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients. J Crit Care 23:11–17CrossRefPubMed
4.
Zurück zum Zitat Heyland D, Jiang X, Day AG, Laverdiere M (2011) Serum beta-d-glucan of critically ill patients with suspected ventilator-associated pneumonia: preliminary observations. J Crit Care 26:536 e531–536 e539CrossRef Heyland D, Jiang X, Day AG, Laverdiere M (2011) Serum beta-d-glucan of critically ill patients with suspected ventilator-associated pneumonia: preliminary observations. J Crit Care 26:536 e531–536 e539CrossRef
5.
Zurück zum Zitat Petri MG, Konig J, Moecke HP, Gramm HJ, Barkow H, Kujath P, Dennhart R, Schafer H, Meyer N, Kalmar P, Thulig P, Muller J, Lode H (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 23:317–325CrossRefPubMed Petri MG, Konig J, Moecke HP, Gramm HJ, Barkow H, Kujath P, Dennhart R, Schafer H, Meyer N, Kalmar P, Thulig P, Muller J, Lode H (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 23:317–325CrossRefPubMed
6.
Zurück zum Zitat Meersseman W, Lagrou K, Spriet I, Maertens J, Verbeken E, Peetermans WE, Van Wijngaerden E (2009) Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 35:1526–1531CrossRefPubMed Meersseman W, Lagrou K, Spriet I, Maertens J, Verbeken E, Peetermans WE, Van Wijngaerden E (2009) Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 35:1526–1531CrossRefPubMed
7.
Zurück zum Zitat Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903CrossRefPubMed Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903CrossRefPubMed
8.
Zurück zum Zitat El-Ebiary M, Torres A, Fabregas N, de la Bellacasa JP, Gonzalez J, Ramirez J, del Bano D, Hernandez C, Jimenez de Anta MT (1997) Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 156:583–590CrossRefPubMed El-Ebiary M, Torres A, Fabregas N, de la Bellacasa JP, Gonzalez J, Ramirez J, del Bano D, Hernandez C, Jimenez de Anta MT (1997) Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 156:583–590CrossRefPubMed
9.
Zurück zum Zitat Rello J, Esandi ME, Diaz E, Mariscal D, Gallego M, Valles J (1998) The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients. Chest 114:146–149CrossRefPubMed Rello J, Esandi ME, Diaz E, Mariscal D, Gallego M, Valles J (1998) The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients. Chest 114:146–149CrossRefPubMed
10.
Zurück zum Zitat Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M (2016) Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial. JAMA 316:1555–1564CrossRefPubMed Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M (2016) Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial. JAMA 316:1555–1564CrossRefPubMed
11.
Zurück zum Zitat Azoulay E, Timsit JF, Tafflet M, de Lassence A, Darmon M, Zahar JR, Adrie C, Garrouste-Orgeas M, Cohen Y, Mourvillier B, Schlemmer B (2006) Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest 129:110–117CrossRefPubMed Azoulay E, Timsit JF, Tafflet M, de Lassence A, Darmon M, Zahar JR, Adrie C, Garrouste-Orgeas M, Cohen Y, Mourvillier B, Schlemmer B (2006) Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest 129:110–117CrossRefPubMed
12.
Zurück zum Zitat Nseir S, Jozefowicz E, Cavestri B, Sendid B, Di Pompeo C, Dewavrin F, Favory R, Roussel-Delvallez M, Durocher A (2007) Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case–control study. Intensive Care Med 33:137–142CrossRefPubMed Nseir S, Jozefowicz E, Cavestri B, Sendid B, Di Pompeo C, Dewavrin F, Favory R, Roussel-Delvallez M, Durocher A (2007) Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case–control study. Intensive Care Med 33:137–142CrossRefPubMed
13.
Zurück zum Zitat Ong DS, Klein Klouwenberg PM, Spitoni C, Bonten MJ, Cremer OL (2013) Nebulised amphotericin B to eradicate Candida colonisation from the respiratory tract in critically ill patients receiving selective digestive decontamination: a cohort study. Crit Care 17:R233CrossRefPubMedPubMedCentral Ong DS, Klein Klouwenberg PM, Spitoni C, Bonten MJ, Cremer OL (2013) Nebulised amphotericin B to eradicate Candida colonisation from the respiratory tract in critically ill patients receiving selective digestive decontamination: a cohort study. Crit Care 17:R233CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Albert M, Williamson D, Muscedere J, Lauzier F, Rotstein C, Kanji S, Jiang X, Hall M, Heyland D (2014) Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study). Intensive Care Med 40:1313–1322CrossRefPubMed Albert M, Williamson D, Muscedere J, Lauzier F, Rotstein C, Kanji S, Jiang X, Hall M, Heyland D (2014) Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study). Intensive Care Med 40:1313–1322CrossRefPubMed
15.
Zurück zum Zitat Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Bohe J, Vanhems P, Monneret G (2010) Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36:1859–1866CrossRefPubMed Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Bohe J, Vanhems P, Monneret G (2010) Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 36:1859–1866CrossRefPubMed
16.
Zurück zum Zitat Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862–874CrossRefPubMedPubMedCentral Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862–874CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Jabra-Rizk MA, Kong EF, Tsui C, Nguyen MH, Clancy CJ, Fidel PL Jr, Noverr M (2016) Candida albicans pathogenesis: fitting within the host-microbe damage response framework. Infect Immun 84:2724–2739CrossRefPubMedPubMedCentral Jabra-Rizk MA, Kong EF, Tsui C, Nguyen MH, Clancy CJ, Fidel PL Jr, Noverr M (2016) Candida albicans pathogenesis: fitting within the host-microbe damage response framework. Infect Immun 84:2724–2739CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Desai JV, van de Veerdonk FL, Lionakis MS (2018) Understanding the role of host immune responses in invasive candidiasis. Intensive Care Med 44:1310–1314CrossRefPubMed Desai JV, van de Veerdonk FL, Lionakis MS (2018) Understanding the role of host immune responses in invasive candidiasis. Intensive Care Med 44:1310–1314CrossRefPubMed
19.
Zurück zum Zitat Demaret J, Walencik A, Jacob MC, Timsit JF, Venet F, Lepape A, Monneret G (2013) Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples. Cytom Part B, Clin Cytom 84:59–62CrossRef Demaret J, Walencik A, Jacob MC, Timsit JF, Venet F, Lepape A, Monneret G (2013) Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples. Cytom Part B, Clin Cytom 84:59–62CrossRef
20.
Zurück zum Zitat Riche F, Gayat E, Barthelemy R, Le Dorze M, Mateo J, Payen D (2015) Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock. Crit Care 19:439CrossRefPubMedPubMedCentral Riche F, Gayat E, Barthelemy R, Le Dorze M, Mateo J, Payen D (2015) Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock. Crit Care 19:439CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Adrie C, Lugosi M, Sonneville R, Souweine B, Ruckly S, Cartier JC, Garrouste-Orgeas M, Schwebel C, Timsit JF (2017) Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission. Ann Intensive care 7:30CrossRefPubMedPubMedCentral Adrie C, Lugosi M, Sonneville R, Souweine B, Ruckly S, Cartier JC, Garrouste-Orgeas M, Schwebel C, Timsit JF (2017) Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission. Ann Intensive care 7:30CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Bailly S, Maubon D, Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF (2016) Impact of antifungal prescription on relative distribution and susceptibility of Candida spp.—Trends over 10 years. J Infect 72:103–111CrossRefPubMed Bailly S, Maubon D, Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF (2016) Impact of antifungal prescription on relative distribution and susceptibility of Candida spp.—Trends over 10 years. J Infect 72:103–111CrossRefPubMed
23.
Zurück zum Zitat Ibn Saied W, Souweine B, Garrouste-Orgeas M, Ruckly S, Darmon M, Bailly S, Cohen Y, Azoulay E, Schwebel C, Radjou A, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Papazian L, Goldgran-Toledano D, Bouadma L, Timsit JF (2017) Respective impact of implementation of prevention strategies, colonization with multiresistant bacteria and antimicrobial use on the risk of early-and late-onset VAP: an analysis of the OUTCOMEREA network. PLoS One 12:e0187791CrossRefPubMedPubMedCentral Ibn Saied W, Souweine B, Garrouste-Orgeas M, Ruckly S, Darmon M, Bailly S, Cohen Y, Azoulay E, Schwebel C, Radjou A, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Papazian L, Goldgran-Toledano D, Bouadma L, Timsit JF (2017) Respective impact of implementation of prevention strategies, colonization with multiresistant bacteria and antimicrobial use on the risk of early-and late-onset VAP: an analysis of the OUTCOMEREA network. PLoS One 12:e0187791CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Monneret G, Venet F, Kullberg BJ, Netea MG (2011) ICU-acquired immunosuppression and the risk for secondary fungal infections. Med Mycol 49(Suppl 1):S17–S23CrossRefPubMed Monneret G, Venet F, Kullberg BJ, Netea MG (2011) ICU-acquired immunosuppression and the risk for secondary fungal infections. Med Mycol 49(Suppl 1):S17–S23CrossRefPubMed
26.
Zurück zum Zitat Venet F, Monneret G (2018) Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol 14:121–137CrossRefPubMed Venet F, Monneret G (2018) Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol 14:121–137CrossRefPubMed
27.
Zurück zum Zitat Cheron A, Floccard B, Allaouchiche B, Guignant C, Poitevin F, Malcus C, Crozon J, Faure A, Guillaume C, Marcotte G, Vulliez A, Monneuse O, Monneret G (2010) Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care 14:R208CrossRefPubMedPubMedCentral Cheron A, Floccard B, Allaouchiche B, Guignant C, Poitevin F, Malcus C, Crozon J, Faure A, Guillaume C, Marcotte G, Vulliez A, Monneuse O, Monneret G (2010) Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care 14:R208CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Venet F, Chung CS, Monneret G, Huang X, Horner B, Garber M, Ayala A (2008) Regulatory T cell populations in sepsis and trauma. J Leukoc Biol 83:523–535CrossRefPubMed Venet F, Chung CS, Monneret G, Huang X, Horner B, Garber M, Ayala A (2008) Regulatory T cell populations in sepsis and trauma. J Leukoc Biol 83:523–535CrossRefPubMed
29.
Zurück zum Zitat Azoulay E, Cohen Y, Zahar JR, Garrouste-Orgeas M, Adrie C, Moine P, de Lassence A, Timsit JF (2004) Practices in non-neutropenic ICU patients with Candida-positive airway specimens. Intensive Care Med 30:1384–1389CrossRefPubMed Azoulay E, Cohen Y, Zahar JR, Garrouste-Orgeas M, Adrie C, Moine P, de Lassence A, Timsit JF (2004) Practices in non-neutropenic ICU patients with Candida-positive airway specimens. Intensive Care Med 30:1384–1389CrossRefPubMed
30.
Zurück zum Zitat Tan X, Zhu S, Yan D, Chen W, Chen R, Zou J, Yan J, Zhang X, Farmakiotis D, Mylonakis E (2016) Candida spp. airway colonization: a potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia. Med Mycol 54:557–566CrossRefPubMed Tan X, Zhu S, Yan D, Chen W, Chen R, Zou J, Yan J, Zhang X, Farmakiotis D, Mylonakis E (2016) Candida spp. airway colonization: a potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia. Med Mycol 54:557–566CrossRefPubMed
31.
Zurück zum Zitat Panpetch W, Somboonna N, Bulan DE, Issara-Amphorn J, Finkelman M, Worasilchai N, Chindamporn A, Palaga T, Tumwasorn S, Leelahavanichkul A (2017) Oral administration of live-or heat-killed Candida albicans worsened cecal ligation and puncture sepsis in a murine model possibly due to an increased serum (1− > 3)-beta-D-glucan. PLoS One 12:e0181439CrossRefPubMedPubMedCentral Panpetch W, Somboonna N, Bulan DE, Issara-Amphorn J, Finkelman M, Worasilchai N, Chindamporn A, Palaga T, Tumwasorn S, Leelahavanichkul A (2017) Oral administration of live-or heat-killed Candida albicans worsened cecal ligation and puncture sepsis in a murine model possibly due to an increased serum (1− > 3)-beta-D-glucan. PLoS One 12:e0181439CrossRefPubMedPubMedCentral
32.
33.
Zurück zum Zitat Roux D, Gaudry S, Khoy-Ear L, Aloulou M, Phillips-Houlbracq M, Bex J, Skurnik D, Denamur E, Monteiro RC, Dreyfuss D, Ricard JD (2013) Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail. Crit Care Med 41:e191–e199CrossRefPubMed Roux D, Gaudry S, Khoy-Ear L, Aloulou M, Phillips-Houlbracq M, Bex J, Skurnik D, Denamur E, Monteiro RC, Dreyfuss D, Ricard JD (2013) Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail. Crit Care Med 41:e191–e199CrossRefPubMed
34.
Zurück zum Zitat Ader F, Jawhara S, Nseir S, Kipnis E, Faure K, Vuotto F, Chemani C, Sendid B, Poulain D, Guery B (2011) Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model. Crit Care 15:R150CrossRefPubMedPubMedCentral Ader F, Jawhara S, Nseir S, Kipnis E, Faure K, Vuotto F, Chemani C, Sendid B, Poulain D, Guery B (2011) Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model. Crit Care 15:R150CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Hogan DA, Kolter R (2002) Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296:2229–2232CrossRefPubMed Hogan DA, Kolter R (2002) Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296:2229–2232CrossRefPubMed
36.
Zurück zum Zitat Cavaillon JM, Annane D (2006) Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 12:151–170PubMed Cavaillon JM, Annane D (2006) Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 12:151–170PubMed
Metadaten
Titel
Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study
verfasst von
Jean-Francois Timsit
Carole Schwebel
Lenka Styfalova
Muriel Cornet
Philippe Poirier
Christiane Forrestier
Stéphane Ruckly
Marie-Christine Jacob
Bertrand Souweine
Publikationsdatum
24.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 6/2019
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-019-05622-0

Weitere Artikel der Ausgabe 6/2019

Intensive Care Medicine 6/2019 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.